Phosphorylation and binding partner analysis of the TSC1-TSC2 complex

Area of Science:

• Genetics and Molecular Biology
• Cellular Signaling
• Oncology

Background:

• Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder characterized by benign tumor formation.
• Mutations in TSC1 or TSC2 tumor suppressor genes disrupt the TSC1-TSC2 protein complex, leading to uncontrolled cell growth.
• The TSC1-TSC2 complex regulates cell growth by inhibiting mTOR signaling via the small GTPase rheb.

Purpose of the Study:

• To identify novel phosphorylation sites on TSC1 and TSC2 proteins.
• To discover new proteins that interact with the TSC1-TSC2 complex.
• To investigate the functional roles of identified phosphorylation sites in TSC1-TSC2 complex activity.

Main Methods:

• Matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS).
• Fourier transform mass spectrometry (FTMS).
• Protein-protein interaction analysis.

Main Results:

• Identified three phosphorylation sites on TSC2 and one novel phosphorylation site on TSC1.
• Characterized the role of these phosphorylation sites in regulating TSC1-TSC2 complex activity.
• Discovered three novel TSC1-TSC2 interacting proteins, including DOCK7, a potential rheb guanine nucleotide exchange factor (GEF).

Conclusions:

• New phosphorylation sites on TSC1 and TSC2 offer insights into TSC complex regulation.
• Identification of DOCK7 suggests a novel mechanism for rheb regulation within the TSC pathway.
• Findings advance understanding of TSC pathogenesis and potential therapeutic targets.